RELATED PRODUCTS NOT AVAILABLE
true
- Overview
- Products & Accessories
- EIFU & Resources
false
Reduced destabilization
The IV catheter reduces the destabilizing effects that can lead to extravasation. The catheter tip features multiple teardrop-shaped diffusion holes to reduce forces that cause catheter motion in the vein by up to 67%.*
Higher flow rates
The IV catheter enables higher flow rates with a smaller gauge catheter (22 to 24 G),*
Confirmed vessel entry
BD Instaflash™ needle technology incorporates a notched needle, which is designed to improve first-stick success and reduce painful hit-and-miss insertions.
Dwell times
BD Vialon™ biomaterial has unique properties that allows it to become more soft and pliable during dwell time.†
Diffusion Catheter tip
- Features multiple teardrop-shaped holes diffuse flow and reduce forces that can cause catheter motion in the vein by up to 67% during contrast enhanced CT procedure.
- Enables higher flow rates on smaller gauge catheters (22 to 24 G) for power injection.*
Integrated system
- The system features an all-in-one catheter and extension set built for your power injector's 325 psi setting.
- A unique all-in-one closed system designed to address common CT IV challenges during power injection procedures.*
- Needs fewer add-on devices, minimizing the number of manipulations which may lead to touch contamination and accidental disconnections.4,5 *
Stabilization platform
- The BD Nexiva Diffusics system incorporates a built-in stabilization platform.
- Minimizes movement and manipulation at the insertion site reducing accidental dislodgement.2**
BD Instaflash™ needle technology
- Designed to confirm immediate vessel entry.
- Quick blood visualization may help improve insertion success and therefore reduce insertion attempts.
BD Vialon™ catheter material
- Clinically demonstrated to dwell up to 144 hours.1
- Reduces the chance of mechanical phlebitis by up to 50%.6†
Luer adapter
- The system features a luer adapter with indication of maximum power injection flow rates and pressure setting.
Centers for Disease Control and Prevention
Catheter stabilization is recognized as an intervention to decrease the risk for phlebitis, catheter migration and dislodgement and may be advantageous in preventing catheter-related bloodstream infections (CRBSIs).7
Infusion Therapy Standards of Practice
Recommend limiting the use of add-on devices to reduce the potential for contamination, additional manipulation, and disconnection.4
Increased clinician safety
98% reduced blood exposure during insertion due to the BD Nexiva IV catheter preassembled system.3*
Increased catheter stabilization
Clinically demonstrated to reduce accidental dislodgement,3‡ meeting Infusion Nursing Society standards4 and CDC guidelines7 for catheter stabilization.
Reduced rate of complications
In a clinical study, results demonstrated a significant reduction in the rate of phlebitis (grade 2 or higher), PIVC-related complications, and infiltration in the closed system versus the open system group.1
BD Nexiva™ Diffusics™ Product Overview Animation
BD Nexiva™ Diffusics™ Closed IV Catheter Insertion Techniques
BD Nexiva™ Diffusics™ - Diffusion Animation
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
Training
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Learn more
Events
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
Learn more
Case Studies
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
Learn more
false
Notes
* Compared to a nondiffusion tip IV catheter
† Compared to a fluorinated ethylene propylene (FEP) catheter
**Compared to B. Braun Introcan Safety® catheter with Bard Statlock® IV Ultra stabilization device.
References
- Gonzalez Lopez J, Arribi Vilela A, Fernandez Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-126.
- Tamura N, Ave S, Hagimoto K, et al. Unfavorable peripheral intravenous catheter replacements an be reduced using an integrated closed intravenous catheter system. J Vasc Access. 2014;15(4):257-263.)
- Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010;33(6):371-384.)
- Infusion Nurses Society;. Infusion therapy standards of practice. J Infus Nurs. 2016:39(1S)S72. Alexander M, Corrigan A. Gorski L, et al. Infusion nursing: an evidence based approach. 3rd ed. St. Louis, MO: Saunders Elsevier; 2010:410.
- Alexander M, Corrigan A. Gorski L, et al. Infusion nursing: an evidence based approach. 3rd ed. St. Louis, MO: Saunders Elsevier; 2010:410.
- Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheter. Annals of Internal Medicine. 1991;114:845-854.
- O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. CDC. 2011:16.
true